2019
DOI: 10.1097/mjt.0000000000000910
|View full text |Cite
|
Sign up to set email alerts
|

Glucagon for Refractory Anaphylaxis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
8
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 3 publications
0
8
0
Order By: Relevance
“…20,26,35,95,110 For patients on β blockers, a few case reports have suggested that glucagon may be beneficial in refractory anaphylaxis. 111,112 Recommendations: Epinephrine may be given every 5 to 15 min IM to treat refractory anaphylaxis, along with the secondary treatments of antihistamines and corticosteroids, as well as inhaled β agonists for patients with bronchospasm (1C). For hypotension after epinephrine administration, IV crystalloids may be given with additional doses of IM epinephrine (1C).…”
Section: Refractory Anaphylaxismentioning
confidence: 99%
See 1 more Smart Citation
“…20,26,35,95,110 For patients on β blockers, a few case reports have suggested that glucagon may be beneficial in refractory anaphylaxis. 111,112 Recommendations: Epinephrine may be given every 5 to 15 min IM to treat refractory anaphylaxis, along with the secondary treatments of antihistamines and corticosteroids, as well as inhaled β agonists for patients with bronchospasm (1C). For hypotension after epinephrine administration, IV crystalloids may be given with additional doses of IM epinephrine (1C).…”
Section: Refractory Anaphylaxismentioning
confidence: 99%
“…20,26,35,95,110 For patients on β blockers, a few case reports have suggested that glucagon may be beneficial in refractory anaphylaxis. 111,112…”
Section: Treatmentmentioning
confidence: 99%
“…Evidence did not support recommendations among different vasopressors [( Gamper et al, 2016 )], so dopamine, norepinephrine and vasopressin can be titrated with careful monitor [( Lieberman et al, 2005 ; Soar et al, 2008 ; Lieberman et al, 2010 ; Simons et al, 2011 ; Campbell et al, 2014 ; Ring et al, 2014 ; Lieberman et al, 2015 )]. Glucagon is pathophysiologically rational for anaphylaxis patients taking β-blockers but only case reports are available to support this [( Thomas and Crawford, 2005 ; Rukma, 2019 )].…”
Section: Resultsmentioning
confidence: 99%
“…The therapeutic effect of adrenaline may be blunted by ß-blockers. In this situation, if adrenaline is not effective, glucagon can be administered intravenously, as it has a mechanism of action independent of the ß-receptors [45,46]…”
Section: Other Treatmentsmentioning
confidence: 99%